Pharmaceutical giant Eli Lilly has begun local production of its oral obesity treatment in Spain to facilitate global distribution. The company is preparing for European regulatory approval while scaling its worldwide manufacturing infrastructure.
- Eli Lilly launched production of its oral obesity therapy in Spain to support supply chains for 120 countries.
- The company is currently awaiting regulatory approval for the drug within the European market.
- This initiative is part of a broader global expansion strategy involving a $50 billion investment.
The company aims to increase its capacity to meet rising international demand for its weight-loss treatments. #EliLilly #Obesity #Pharma #Spain @LillyPad